The IL‐6 signaling complex is a critical driver, negative prognostic factor, and therapeutic target in diffuse large B‐cell lymphoma
Hind Hashwah(University of Zurich), Anne Müller(University of Zurich)
Cited by 70
Related Papers
Myc-mediated repression of microRNA-34a promotes high-grade transformation of B-cell lymphoma by dysregulation of FoxP1
|Blood|2011|166
Inactivation of CREBBP expands the germinal center B cell compartment, down-regulates MHCII expression and promotes DLBCL growth
|Proceedings of the National Academy of Sciences|2017|117
DUSP4 deficiency caused by promoter hypermethylation drives JNK signaling and tumor cell survival in diffuse large B cell lymphoma
|The Journal of Experimental Medicine|2015|69
Transmaternal Helicobacter pylori exposure reduces allergic airway inflammation in offspring through regulatory T cells
|Journal of Allergy and Clinical Immunology|2018|55